209 related articles for article (PubMed ID: 31114368)
1. The systemic inflammation response index predicts survival and recurrence in patients with resectable pancreatic ductal adenocarcinoma.
Li S; Xu H; Wang W; Gao H; Li H; Zhang S; Xu J; Zhang W; Xu S; Li T; Ni Q; Yu X; Wu C; Liu L
Cancer Manag Res; 2019; 11():3327-3337. PubMed ID: 31114368
[No Abstract] [Full Text] [Related]
2. Systemic Inflammation Response Index (SIRI), cancer stem cells and survival of localised gastric adenocarcinoma after curative resection.
Li S; Lan X; Gao H; Li Z; Chen L; Wang W; Song S; Wang Y; Li C; Zhang H; Xue Y
J Cancer Res Clin Oncol; 2017 Dec; 143(12):2455-2468. PubMed ID: 28828692
[TBL] [Abstract][Full Text] [Related]
3. A Systemic Inflammation Response Index (SIRI)-Based Nomogram for Predicting the Recurrence of Early Stage Hepatocellular Carcinoma After Radiofrequency Ablation.
Xin Y; Zhang X; Li Y; Yang Y; Chen Y; Wang Y; Zhou X; Li X
Cardiovasc Intervent Radiol; 2022 Jan; 45(1):43-53. PubMed ID: 34561739
[TBL] [Abstract][Full Text] [Related]
4. Pretreatment Systemic Inflammation Response Index in Patients with Breast Cancer Treated with Neoadjuvant Chemotherapy as a Useful Prognostic Indicator.
Chen L; Kong X; Wang Z; Wang X; Fang Y; Wang J
Cancer Manag Res; 2020; 12():1543-1567. PubMed ID: 32184659
[TBL] [Abstract][Full Text] [Related]
5. Prognostic Value of the Systemic Inflammation Response Index in Patients with Adenocarcinoma of the Oesophagogastric Junction: A Propensity Score-Matched Analysis.
Chen Y; Jin M; Shao Y; Xu G
Dis Markers; 2019; 2019():4659048. PubMed ID: 31781301
[TBL] [Abstract][Full Text] [Related]
6. High preoperative CEA and systemic inflammation response index (C-SIRI) predict unfavorable survival of resectable colorectal cancer.
Cai H; Chen Y; Zhang Q; Liu Y; Jia H
World J Surg Oncol; 2023 Jun; 21(1):178. PubMed ID: 37291634
[TBL] [Abstract][Full Text] [Related]
7. High Preoperative Fibrinogen and Systemic Inflammation Response Index (F-SIRI) Predict Unfavorable Survival of Resectable Gastric Cancer Patients.
Gao W; Zhang F; Ma T; Hao J
J Gastric Cancer; 2020 Jun; 20(2):202-211. PubMed ID: 32596003
[TBL] [Abstract][Full Text] [Related]
8. The preoperative systemic inflammation response index (SIRI) independently predicts survival in postmenopausal women with breast cancer.
Hua X; Long ZQ; Huang X; Deng JP; Wen W; He ZY; Guo L; Zhang WW; Lin HX
Curr Probl Cancer; 2020 Aug; 44(4):100560. PubMed ID: 32122667
[TBL] [Abstract][Full Text] [Related]
9. A novel systemic inflammation response index (SIRI) for predicting the survival of patients with pancreatic cancer after chemotherapy.
Qi Q; Zhuang L; Shen Y; Geng Y; Yu S; Chen H; Liu L; Meng Z; Wang P; Chen Z
Cancer; 2016 Jul; 122(14):2158-67. PubMed ID: 27152949
[TBL] [Abstract][Full Text] [Related]
10. Markers of tumor inflammation as prognostic factors for overall survival in patients with advanced pancreatic cancer receiving first-line FOLFIRINOX chemotherapy.
Kamposioras K; Papaxoinis G; Dawood M; Appleyard J; Collinson F; Lamarca A; Ahmad U; Hubner RA; Wright F; Pihlak R; Damyanova I; Razzaq B; Valle JW; McNamara MG; Anthoney A
Acta Oncol; 2022 May; 61(5):583-590. PubMed ID: 35392758
[TBL] [Abstract][Full Text] [Related]
11. High Systemic Inflammation Response Index (SIRI) Indicates Poor Outcome in Gallbladder Cancer Patients with Surgical Resection: A Single Institution Experience in China.
Sun L; Hu W; Liu M; Chen Y; Jin B; Xu H; Du S; Xu Y; Zhao H; Lu X; Sang X; Zhong S; Yang H; Mao Y
Cancer Res Treat; 2020 Oct; 52(4):1199-1210. PubMed ID: 32718144
[TBL] [Abstract][Full Text] [Related]
12. Low Systemic Inflammation Response Index Predicts Good Prognosis in Locally Advanced Pancreatic Carcinoma Patients Treated with Concurrent Chemoradiotherapy.
Topkan E; Mertsoylu H; Kucuk A; Besen AA; Sezer A; Sezen D; Bolukbasi Y; Selek U; Pehlivan B
Gastroenterol Res Pract; 2020; 2020():5701949. PubMed ID: 32802045
[TBL] [Abstract][Full Text] [Related]
13. Combining the systemic inflammation response index and prognostic nutritional index to predict the prognosis of locally advanced elderly esophageal squamous cell carcinoma patients undergoing definitive radiotherapy.
Yan K; Wei W; Shen W; Du X; Zhu S; Zhao H; Wang X; Yang J; Zhang X; Deng W
J Gastrointest Oncol; 2022 Feb; 13(1):13-25. PubMed ID: 35284132
[TBL] [Abstract][Full Text] [Related]
14. Pre-treatment systemic inflammation response index and systemic immune inflammation in patients with primary central nerve system lymphoma as a useful prognostic indicator.
Matsuda R; Maeoka R; Morimoto T; Nakazawa T; Morisaki Y; Yokoyama S; Kotsugi M; Takeshima Y; Yamada S; Nishimura F; Park YS; Nakagawa I
J Neurooncol; 2024 Apr; ():. PubMed ID: 38658464
[TBL] [Abstract][Full Text] [Related]
15. Systemic Inflammation Response Index Predicts Survival Outcomes in Glioblastoma Multiforme Patients Treated with Standard Stupp Protocol.
Topkan E; Kucuk A; Ozdemir Y; Mertsoylu H; Besen AA; Sezen D; Bolukbasi Y; Pehlivan B; Selek U
J Immunol Res; 2020; 2020():8628540. PubMed ID: 33274245
[TBL] [Abstract][Full Text] [Related]
16. Pretreatment systemic inflammation response index (SIRI) is an independent predictor of survival in unresectable stage III non-small cell lung cancer treated with chemoradiotherapy: a two-center retrospective study.
Hu M; Xu Q; Yang S; Han S; Zhu Y; Lin Q; Sun X; Liu H; Xu Y
Ann Transl Med; 2020 Oct; 8(20):1310. PubMed ID: 33209890
[TBL] [Abstract][Full Text] [Related]
17. Combination of Systemic Inflammation Response Index and Platelet-to-Lymphocyte Ratio as a Novel Prognostic Marker of Upper Tract Urothelial Carcinoma After Radical Nephroureterectomy.
Zheng Y; Chen Y; Chen J; Chen W; Pan Y; Bao L; Gao X
Front Oncol; 2019; 9():914. PubMed ID: 31620369
[TBL] [Abstract][Full Text] [Related]
18. The systemic inflammation response index predicts the survival of patients with clinical T1-2N0 oral squamous cell carcinoma.
Song F; Cai H; Liao Y; Huang S; Jiang Y; Liang J; Xie N; Hou J
Oral Dis; 2022 Apr; 28(3):600-610. PubMed ID: 33486833
[TBL] [Abstract][Full Text] [Related]
19. Independent effect of postoperative neutrophil-to-lymphocyte ratio on the survival of pancreatic ductal adenocarcinoma with open distal pancreatosplenectomy and its nomogram-based prediction.
Pu N; Yin H; Zhao G; Nuerxiati A; Wang D; Xu X; Kuang T; Jin D; Lou W; Wu W
J Cancer; 2019; 10(24):5935-5943. PubMed ID: 31762803
[No Abstract] [Full Text] [Related]
20. The Systemic-immune-inflammation Index Independently Predicts Survival and Recurrence in Resectable Pancreatic Cancer and its Prognostic Value Depends on Bilirubin Levels: A Retrospective Multicenter Cohort Study.
Aziz MH; Sideras K; Aziz NA; Mauff K; Haen R; Roos D; Saida L; Suker M; van der Harst E; Mieog JS; Bonsing BA; Klaver Y; Koerkamp BG; van Eijck CH
Ann Surg; 2019 Jul; 270(1):139-146. PubMed ID: 29334554
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
